Company
Product List
Offer to buy
Offer to sell
登录
添加会员
求助
Languages
English
繁體中文
簡體中文
Wuhan Demeikai Biotechnology Co., Ltd
回首页
公司简介
产品橱窗
影音视听
寄出询问函
联络我们
Recommended Results
Sarms Mk677 / Mk-677 /MK 677/ Ibutamoren Mesylate CAS 159752-10-0 High Quality for Muscle Building
产品分类 :
化學->藥品->化學藥品
看放大图
看放大图
看放大图
产品规格
Model No: sarms
Country
CN
Brand
DMK
Materials
srams
Size
10 millimeters
Weight
25kg
Color
white
Packing
Aluminum Foil Bag/Carton
Minimum Order
10g
Payment Term
wester union
moneygram
payapl
l/C
T/T
产品描述
mk-677, rad140, gw501516, lgd4033, S-4, mk-2866, sr9009, yk-11
mk-377
Basic Info.
Chemical Name:MK-677
Other Name:Ibutamoren,Nutrobal
CAS:159752-10-0
MF:C27H36N4O5S.CH4O3S
MW:624.776
Purity:99% min
MOQ:10g
Appearance:white powder
Description:
MK-677 is a revolutionary non-peptide hormone (GH) secretagogue. MK-0677 triggers GH pulse discharge through the pituitary and hypothalamic receptors mimicking the GH stimulating action of the endogenous hormone ghrelin. It has been widely demonstrated to upsurge the release of, and creates sustained increases in plasma levels of several hormones including hormone and , but without affecting cortisol levels.
It is currently under development as a potential treatment for reduced levels of these hormones, such as in hormone deficient children or elderly adults, and human studies have shown it to increase both muscle mass and bone mineral density, making it a promising therapy for the treatment of frailty in the elderly. MK-0677 also alters basal metabolism of body fat and so may have application in the future treatment of obesity.
MK-677 is an oral GH SECRETAGOGUE that provides higher amplitude to the dozen or more gh pulses put out by the pituitary gland over the 25 hour half-life of the drug. Once daily use before bed at a dose of 25mg provides all of the benefits of elevated GH and such as deeper sleep with more vivid dreams, improved skin, faster hair and nail growth, fat loss, lean muscle gain, increased strength, greater nitrogen retention the the skeletal muscles, greater protein synthesis, etc.
Application:
Trials testing the effects of this GHS on fighting obesity showed an increase in lean body mass, but neither total, nor visceral adipose tissue was effected. This study gave subjects 25mgs of Nutrobal per day for 8 weeks. The subjects showed an increase in basal metabolic rate after 2 weeks, and an increase in serum levels of GH, and binding protein-3. Increase in lean body mass was hypothesized to be caused by an increase in calorie deposition into the muscle and appetite decrease as opposed to reducing fat storage directly.
A study done for the treatment of osteoporosis and bone mineral density showed some increase in bone density, so there is a true impact on bone mineral density. This can help with injury recovery during your cycle.
Other possible benefits of Nutrobal are associated with improved sleep, improved complexion, increase in energy levels, increase nitrogen retention, increase strength and an improved sense of well being. In addition, some studies also suggest that an increased immune system response was caused by Nutrobal (Mk-677), meaning it boosts the immune system to a degree.
Function:
2. Anabolic at doses above 50mg
3. Great for strength
4. Great for muscle hardness
5. Great for enhanced vascularity
6. Great for endurance (aerobic or anaerobic)
7. Accelerated fat loss above 50mg
8. Joint healing effects
[ 返回产品型录 ]
Commerce 会员:
请登录您的帐号跟口令,系统将为您填入您的相关资料
帐号:
口令:
记住我的帐号
填写下列表格并寄送询问函.所有的询问信函将会自动寄发给你想联络的公司
主題
內容
( 请勿输入公司名称、Email、电话、传真、网址 )
公司简介:
*
公司名称
*
E-mail
*
国家
Please Select Your Country
United States
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaidjan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
Former Czechoslovakia
Former USSR
France
France (European Territory)
French Guyana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Great Britain
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion (French)
Romania
Russian Federation
Rwanda
S. Georgia & S. Sandwich Isls.
Saint Helena
Saint Kitts & Nevis Anguilla
Saint Lucia
Saint Pierre and Miquelon
Saint Tome (Sao Tome) and Principe
Saint Vincent & Grenadines
Samoa
San Marino
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Taiwan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City State
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (USA)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe
*
联络人
网址
*
电话
-
-
传真
-
-
*
邮递区号
*
城市
*
街道地址
*
企业形态
批发商
出口商
进口商
制造商
大盘商
零售商
代理商
Retrofitter
使用者
其他, 请详细说明:
*
安全口令
请输入所显示的安全口令
网站导览 l
隐私权政策 l
服务团队 l
合作提案 l
联络我们 l
帮帮我 l
广告刊登l
B2B商业伙伴
.